Duloxetine
Product Images NDC 53002-1503

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Duloxetine (NDC 53002-1503). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure1 (Duloxetine Fig1)

Figure1 (Duloxetine Fig1)
FDA Label Image

Figure10 (Duloxetine Fig10)

Figure10 (Duloxetine Fig10)
FDA Label Image

Figure2 (Duloxetine Fig2)

Figure2 (Duloxetine Fig2)
The text indicates a graph showing the proportion of patients with relapse over time. The x-axis represents the time from randomization to relapse in days, ranging from 0 to 300. The y-axis represents the proportion of patients with relapse, ranging from 0.0% to 10.0%. The graph compares the treatment outcomes of a placebo group and a group treated with duloxetine.*
FDA Label Image

Figure3 (Duloxetine Fig3)

Figure3 (Duloxetine Fig3)
FDA Label Image

Figure4 (Duloxetine Fig4)

Figure4 (Duloxetine Fig4)
FDA Label Image

Figure5 (Duloxetine Fig5)

Figure5 (Duloxetine Fig5)
FDA Label Image

Figure6 (Duloxetine Fig6)

Figure6 (Duloxetine Fig6)
FDA Label Image

Figure8 (Duloxetine Fig8)

Figure8 (Duloxetine Fig8)
FDA Label Image

Figure9 (Duloxetine Fig9)

Figure9 (Duloxetine Fig9)
FDA Label Image

Structure (Duloxetine Structure)

Structure (Duloxetine Structure)
FDA Label Image

Label Image (Lbl530021503)

Label Image (Lbl530021503)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.